Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis
Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We establish...
Gespeichert in:
Veröffentlicht in: | The Journal of experimental medicine 2020-05, Vol.217 (5) |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 5 |
container_start_page | |
container_title | The Journal of experimental medicine |
container_volume | 217 |
creator | Cunha, Maria Inês Su, Minhui Cantuti-Castelvetri, Ludovico Müller, Stephan A Schifferer, Martina Djannatian, Minou Alexopoulos, Ioannis van der Meer, Franziska Winkler, Anne van Ham, Tjakko J Schmid, Bettina Lichtenthaler, Stefan F Stadelmann, Christine Simons, Mikael |
description | Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes. |
doi_str_mv | 10.1084/jem.20191390 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7201919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2400546151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</originalsourceid><addsrcrecordid>eNpVkU1P3DAQhq0KVJZtb5yrHDk0MP5KnEsltKIFCakc2rPl2JOtwbHBzoL235N2F0RPI808emc0DyEnFM4oKHF-h-MZA9pR3sEHsqBSQN1Jrg7IAoCxmgK0R-S4lDsAKoRsPpIjzqBVTasW5P42p9rHIZhxNFPK28rYyT-ZyadYDSmE9OzjunI4bjH4uOv7UmV83PiMbmZytZtVNqDJJlqsTHRVCn6dHEaX0xojFl8-kcPBhIKf93VJfn-__LW6qm9-_rheXdzUlisx1dxZZjpsB96i610vm86CsVJQ6RgVrULHBmWhd0x1lraqFxK5kD0frLSy4UvybZf7sOlHdBbjlE3QD9mPJm91Ml7_P4n-j16nJ93--2M3B5zuA3J63GCZ9OiLxRBMxLQpmgkAKRoq6Yx-3aE2p1IyDm9rKOi_fvTsR7_6mfEv7097g1-F8Be20ZAu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2400546151</pqid></control><display><type>article</type><title>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Cunha, Maria Inês ; Su, Minhui ; Cantuti-Castelvetri, Ludovico ; Müller, Stephan A ; Schifferer, Martina ; Djannatian, Minou ; Alexopoulos, Ioannis ; van der Meer, Franziska ; Winkler, Anne ; van Ham, Tjakko J ; Schmid, Bettina ; Lichtenthaler, Stefan F ; Stadelmann, Christine ; Simons, Mikael</creator><creatorcontrib>Cunha, Maria Inês ; Su, Minhui ; Cantuti-Castelvetri, Ludovico ; Müller, Stephan A ; Schifferer, Martina ; Djannatian, Minou ; Alexopoulos, Ioannis ; van der Meer, Franziska ; Winkler, Anne ; van Ham, Tjakko J ; Schmid, Bettina ; Lichtenthaler, Stefan F ; Stadelmann, Christine ; Simons, Mikael</creatorcontrib><description>Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.</description><identifier>ISSN: 0022-1007</identifier><identifier>EISSN: 1540-9538</identifier><identifier>DOI: 10.1084/jem.20191390</identifier><identifier>PMID: 32078678</identifier><language>eng</language><publisher>United States: Rockefeller University Press</publisher><subject>Animals ; Axons - drug effects ; Axons - pathology ; Cells, Cultured ; Demyelinating Diseases - pathology ; Disease Models, Animal ; Inflammation - pathology ; Larva - drug effects ; Lysophosphatidylcholines - metabolism ; Mice ; Microglia - drug effects ; Microglia - metabolism ; Mutation - genetics ; Myelin Sheath - drug effects ; Myelin Sheath - metabolism ; Myelin Sheath - pathology ; Myeloid Differentiation Factor 88 - metabolism ; Neuroscience ; Oligodendroglia - drug effects ; Oligodendroglia - metabolism ; Oligodendroglia - pathology ; Phagocytes - drug effects ; Phagocytes - pathology ; Phagosomes - drug effects ; Phagosomes - metabolism ; Proteome - metabolism ; Remyelination - drug effects ; Spinal Cord - pathology ; Tumor Necrosis Factor-alpha - pharmacology ; Zebrafish</subject><ispartof>The Journal of experimental medicine, 2020-05, Vol.217 (5)</ispartof><rights>2020 Cunha et al.</rights><rights>2020 Cunha et al. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</citedby><cites>FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</cites><orcidid>0000-0001-5329-192X ; 0000-0001-5803-6098 ; 0000-0003-3414-307X ; 0000-0002-2175-8713 ; 0000-0003-1766-5458</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32078678$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cunha, Maria Inês</creatorcontrib><creatorcontrib>Su, Minhui</creatorcontrib><creatorcontrib>Cantuti-Castelvetri, Ludovico</creatorcontrib><creatorcontrib>Müller, Stephan A</creatorcontrib><creatorcontrib>Schifferer, Martina</creatorcontrib><creatorcontrib>Djannatian, Minou</creatorcontrib><creatorcontrib>Alexopoulos, Ioannis</creatorcontrib><creatorcontrib>van der Meer, Franziska</creatorcontrib><creatorcontrib>Winkler, Anne</creatorcontrib><creatorcontrib>van Ham, Tjakko J</creatorcontrib><creatorcontrib>Schmid, Bettina</creatorcontrib><creatorcontrib>Lichtenthaler, Stefan F</creatorcontrib><creatorcontrib>Stadelmann, Christine</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><title>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</title><title>The Journal of experimental medicine</title><addtitle>J Exp Med</addtitle><description>Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.</description><subject>Animals</subject><subject>Axons - drug effects</subject><subject>Axons - pathology</subject><subject>Cells, Cultured</subject><subject>Demyelinating Diseases - pathology</subject><subject>Disease Models, Animal</subject><subject>Inflammation - pathology</subject><subject>Larva - drug effects</subject><subject>Lysophosphatidylcholines - metabolism</subject><subject>Mice</subject><subject>Microglia - drug effects</subject><subject>Microglia - metabolism</subject><subject>Mutation - genetics</subject><subject>Myelin Sheath - drug effects</subject><subject>Myelin Sheath - metabolism</subject><subject>Myelin Sheath - pathology</subject><subject>Myeloid Differentiation Factor 88 - metabolism</subject><subject>Neuroscience</subject><subject>Oligodendroglia - drug effects</subject><subject>Oligodendroglia - metabolism</subject><subject>Oligodendroglia - pathology</subject><subject>Phagocytes - drug effects</subject><subject>Phagocytes - pathology</subject><subject>Phagosomes - drug effects</subject><subject>Phagosomes - metabolism</subject><subject>Proteome - metabolism</subject><subject>Remyelination - drug effects</subject><subject>Spinal Cord - pathology</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Zebrafish</subject><issn>0022-1007</issn><issn>1540-9538</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1P3DAQhq0KVJZtb5yrHDk0MP5KnEsltKIFCakc2rPl2JOtwbHBzoL235N2F0RPI808emc0DyEnFM4oKHF-h-MZA9pR3sEHsqBSQN1Jrg7IAoCxmgK0R-S4lDsAKoRsPpIjzqBVTasW5P42p9rHIZhxNFPK28rYyT-ZyadYDSmE9OzjunI4bjH4uOv7UmV83PiMbmZytZtVNqDJJlqsTHRVCn6dHEaX0xojFl8-kcPBhIKf93VJfn-__LW6qm9-_rheXdzUlisx1dxZZjpsB96i610vm86CsVJQ6RgVrULHBmWhd0x1lraqFxK5kD0frLSy4UvybZf7sOlHdBbjlE3QD9mPJm91Ml7_P4n-j16nJ93--2M3B5zuA3J63GCZ9OiLxRBMxLQpmgkAKRoq6Yx-3aE2p1IyDm9rKOi_fvTsR7_6mfEv7097g1-F8Be20ZAu</recordid><startdate>20200504</startdate><enddate>20200504</enddate><creator>Cunha, Maria Inês</creator><creator>Su, Minhui</creator><creator>Cantuti-Castelvetri, Ludovico</creator><creator>Müller, Stephan A</creator><creator>Schifferer, Martina</creator><creator>Djannatian, Minou</creator><creator>Alexopoulos, Ioannis</creator><creator>van der Meer, Franziska</creator><creator>Winkler, Anne</creator><creator>van Ham, Tjakko J</creator><creator>Schmid, Bettina</creator><creator>Lichtenthaler, Stefan F</creator><creator>Stadelmann, Christine</creator><creator>Simons, Mikael</creator><general>Rockefeller University Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-5329-192X</orcidid><orcidid>https://orcid.org/0000-0001-5803-6098</orcidid><orcidid>https://orcid.org/0000-0003-3414-307X</orcidid><orcidid>https://orcid.org/0000-0002-2175-8713</orcidid><orcidid>https://orcid.org/0000-0003-1766-5458</orcidid></search><sort><creationdate>20200504</creationdate><title>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</title><author>Cunha, Maria Inês ; Su, Minhui ; Cantuti-Castelvetri, Ludovico ; Müller, Stephan A ; Schifferer, Martina ; Djannatian, Minou ; Alexopoulos, Ioannis ; van der Meer, Franziska ; Winkler, Anne ; van Ham, Tjakko J ; Schmid, Bettina ; Lichtenthaler, Stefan F ; Stadelmann, Christine ; Simons, Mikael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-3dc2a9e7f37edbdb569c0ac5415d21478ed2f8c0bd289c178b45e345b3fc5c563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Animals</topic><topic>Axons - drug effects</topic><topic>Axons - pathology</topic><topic>Cells, Cultured</topic><topic>Demyelinating Diseases - pathology</topic><topic>Disease Models, Animal</topic><topic>Inflammation - pathology</topic><topic>Larva - drug effects</topic><topic>Lysophosphatidylcholines - metabolism</topic><topic>Mice</topic><topic>Microglia - drug effects</topic><topic>Microglia - metabolism</topic><topic>Mutation - genetics</topic><topic>Myelin Sheath - drug effects</topic><topic>Myelin Sheath - metabolism</topic><topic>Myelin Sheath - pathology</topic><topic>Myeloid Differentiation Factor 88 - metabolism</topic><topic>Neuroscience</topic><topic>Oligodendroglia - drug effects</topic><topic>Oligodendroglia - metabolism</topic><topic>Oligodendroglia - pathology</topic><topic>Phagocytes - drug effects</topic><topic>Phagocytes - pathology</topic><topic>Phagosomes - drug effects</topic><topic>Phagosomes - metabolism</topic><topic>Proteome - metabolism</topic><topic>Remyelination - drug effects</topic><topic>Spinal Cord - pathology</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Zebrafish</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cunha, Maria Inês</creatorcontrib><creatorcontrib>Su, Minhui</creatorcontrib><creatorcontrib>Cantuti-Castelvetri, Ludovico</creatorcontrib><creatorcontrib>Müller, Stephan A</creatorcontrib><creatorcontrib>Schifferer, Martina</creatorcontrib><creatorcontrib>Djannatian, Minou</creatorcontrib><creatorcontrib>Alexopoulos, Ioannis</creatorcontrib><creatorcontrib>van der Meer, Franziska</creatorcontrib><creatorcontrib>Winkler, Anne</creatorcontrib><creatorcontrib>van Ham, Tjakko J</creatorcontrib><creatorcontrib>Schmid, Bettina</creatorcontrib><creatorcontrib>Lichtenthaler, Stefan F</creatorcontrib><creatorcontrib>Stadelmann, Christine</creatorcontrib><creatorcontrib>Simons, Mikael</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cunha, Maria Inês</au><au>Su, Minhui</au><au>Cantuti-Castelvetri, Ludovico</au><au>Müller, Stephan A</au><au>Schifferer, Martina</au><au>Djannatian, Minou</au><au>Alexopoulos, Ioannis</au><au>van der Meer, Franziska</au><au>Winkler, Anne</au><au>van Ham, Tjakko J</au><au>Schmid, Bettina</au><au>Lichtenthaler, Stefan F</au><au>Stadelmann, Christine</au><au>Simons, Mikael</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis</atitle><jtitle>The Journal of experimental medicine</jtitle><addtitle>J Exp Med</addtitle><date>2020-05-04</date><risdate>2020</risdate><volume>217</volume><issue>5</issue><issn>0022-1007</issn><eissn>1540-9538</eissn><abstract>Remyelination requires innate immune system function, but how exactly microglia and macrophages clear myelin debris after injury and tailor a specific regenerative response is unclear. Here, we asked whether pro-inflammatory microglial/macrophage activation is required for this process. We established a novel toxin-based spinal cord model of de- and remyelination in zebrafish and showed that pro-inflammatory NF-κB-dependent activation in phagocytes occurs rapidly after myelin injury. We found that the pro-inflammatory response depends on myeloid differentiation primary response 88 (MyD88). MyD88-deficient mice and zebrafish were not only impaired in the degradation of myelin debris, but also in initiating the generation of new oligodendrocytes for myelin repair. We identified reduced generation of TNF-α in lesions of MyD88-deficient animals, a pro-inflammatory molecule that was able to induce the generation of new premyelinating oligodendrocytes. Our study shows that pro-inflammatory phagocytic signaling is required for myelin debris degradation, for inflammation resolution, and for initiating the generation of new oligodendrocytes.</abstract><cop>United States</cop><pub>Rockefeller University Press</pub><pmid>32078678</pmid><doi>10.1084/jem.20191390</doi><orcidid>https://orcid.org/0000-0001-5329-192X</orcidid><orcidid>https://orcid.org/0000-0001-5803-6098</orcidid><orcidid>https://orcid.org/0000-0003-3414-307X</orcidid><orcidid>https://orcid.org/0000-0002-2175-8713</orcidid><orcidid>https://orcid.org/0000-0003-1766-5458</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1007 |
ispartof | The Journal of experimental medicine, 2020-05, Vol.217 (5) |
issn | 0022-1007 1540-9538 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7201919 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
subjects | Animals Axons - drug effects Axons - pathology Cells, Cultured Demyelinating Diseases - pathology Disease Models, Animal Inflammation - pathology Larva - drug effects Lysophosphatidylcholines - metabolism Mice Microglia - drug effects Microglia - metabolism Mutation - genetics Myelin Sheath - drug effects Myelin Sheath - metabolism Myelin Sheath - pathology Myeloid Differentiation Factor 88 - metabolism Neuroscience Oligodendroglia - drug effects Oligodendroglia - metabolism Oligodendroglia - pathology Phagocytes - drug effects Phagocytes - pathology Phagosomes - drug effects Phagosomes - metabolism Proteome - metabolism Remyelination - drug effects Spinal Cord - pathology Tumor Necrosis Factor-alpha - pharmacology Zebrafish |
title | Pro-inflammatory activation following demyelination is required for myelin clearance and oligodendrogenesis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A55%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pro-inflammatory%20activation%20following%20demyelination%20is%20required%20for%20myelin%20clearance%20and%20oligodendrogenesis&rft.jtitle=The%20Journal%20of%20experimental%20medicine&rft.au=Cunha,%20Maria%20In%C3%AAs&rft.date=2020-05-04&rft.volume=217&rft.issue=5&rft.issn=0022-1007&rft.eissn=1540-9538&rft_id=info:doi/10.1084/jem.20191390&rft_dat=%3Cproquest_pubme%3E2400546151%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2400546151&rft_id=info:pmid/32078678&rfr_iscdi=true |